Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis : Results from Population-Based Surveillance of Candidemia in Spain
- 1 April 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (4) , 1506-1509
Abstract
We describe the prevalences and susceptibility profiles of two recently described species, Candida metapsilosis and Candida orthopsilosis , related to Candida parapsilosis in candidemia. The prevalences of these species (1.7% for C. metapsilosis and 1.4% for C. orthopsilosis ) are significant. Differences observed in their susceptibility profiles could have therapeutic importance.Keywords
This publication has 18 references indexed in Scilit:
- Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosisJournal of Clinical Microbiology, 2008
- Paradoxical Growth Effect of Caspofungin Observed on Biofilms and Planktonic Cells of Five Different Candida SpeciesAntimicrobial Agents and Chemotherapy, 2007
- Genotyping of Candida orthopsilosis Clinical Isolates by Amplification Fragment Length Polymorphism Reveals Genetic Diversity among Independent Isolates and Strain Maintenance within PatientsJournal of Clinical Microbiology, 2007
- Global Surveillance of In Vitro Activity of Micafungin against Candida : a Comparison with Caspofungin by CLSI-Recommended MethodsJournal of Clinical Microbiology, 2006
- Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003Journal of Clinical Microbiology, 2006
- In Vitro Activities of Anidulafungin against More than 2,500 Clinical Isolates of Candida spp., Including 315 Isolates Resistant to FluconazoleJournal of Clinical Microbiology, 2005
- In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002–2003Journal of Antimicrobial Chemotherapy, 2005
- Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and IIIJournal of Clinical Microbiology, 2005
- Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeastsClinical Microbiology and Infection, 2003
- Biotype Diversity of Candida parapsilosis and Its Relationship to the Clinical Source and Experimental PathogenicityThe Journal of Infectious Diseases, 1995